MODULATION DU RECEPTEUR P2X7 PAR DES DERIVES D'ACIDES HYALURONIQUES

MODULATION DU RECEPTEUR P2X7 PAR DES DERIVES D'ACIDES HYALURONIQUES

Case comprises: a first container comprising hyaluronic acid or its derivatives having molecular weight of 10 5>-3x 10 6>Daltons, preferably 8x 10 5>-1.5x 10 6>Daltons with a final mass percentage of hyaluronic acid formulation or one of its derivatives (0.001-90%, preferably 0.05-10%) a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PAULOIN THIERRY, RAT PATRICE, DUTOT MELODY, RANNOU ALEXIS
Format: Patent
Sprache:fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Case comprises: a first container comprising hyaluronic acid or its derivatives having molecular weight of 10 5>-3x 10 6>Daltons, preferably 8x 10 5>-1.5x 10 6>Daltons with a final mass percentage of hyaluronic acid formulation or one of its derivatives (0.001-90%, preferably 0.05-10%) and a food grade excipient or excipient; and a second container comprising an active substance and a preservative with a final mass percentage of 0.0001-5%. ACTIVITY : Ophthalmological; Tranquilizer. MECHANISM OF ACTION : None given.